Physician profile
Eric Alan Monesmith
NPI 1669424891
$15,557.98
in general payments reported to CMS, 2019-2025
7 companies · $367 in 2025
The $367 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,659 · 2020: $9,793 · 2021: $407 · 2022: $1,769 · 2023: $425 · 2024: $138 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,116.72 | 2019-2025 | Triathlon, Mako, Exeter |
| Davol INC. | $150.58 | 2023 | Arista Ah Flexitip |
| Encore Medical, LP | $110.73 | 2024-2025 | Djo Surgical |
| Pacira Pharmaceuticals Incorporated | $78.97 | 2019 | |
| Smith+Nephew, INC. | $52.51 | 2025 | Legion Revision, Tandem, Journey II |
| Vertex Pharmaceuticals Incorporated | $26.57 | 2025 | |
| Heron Therapeutics, INC. | $21.90 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Monesmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.